Whole-body MRI as a screening tool?

European Journal of Radiology

Volumn 70, Issue 3, 2009, Pages 452-462

  Ladd, Susanne C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Magnetic resonance; Magnetic resonance angiography; Screening; Tumour; Whole body

Indexed keywords

CARDIAC MR; EARLY DETECTION; FIELD OF VIEWS; INCIDENTAL FINDINGS; MAGNETIC RESONANCE ANGIOGRAPHY; MR ANGIOGRAPHY; POTENTIAL PROBLEMS; RENAL CARCINOMA; RISK FACTORS; SCREENING PROTOCOL; SCREENING TOOL; SURFACE COILS; TECHNICAL REQUIREMENT; TUMOUR; WELL BEING; WHOLE-BODY;

ANGIOGRAPHY; HEALTH RISKS; MAGNETIC RESONANCE;

TUMORS;

ARTICLE; ATHEROSCLEROSIS; BRONCHUS CANCER; CANCER SCREENING; CLINICAL PROTOCOL; COLON CANCER; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMAN; INCIDENTAL FINDING; KIDNEY CARCINOMA; MAGNETIC RESONANCE ANGIOGRAPHY; PATIENT POSITIONING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCREENING TEST; WHOLE BODY MRI;

ATHEROSCLEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; NEOPLASMS; RISK ASSESSMENT; WHOLE BODY IMAGING;

EID: 67349228854     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.02.011     Document Type: Article

References (75)

1. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19-22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
2. Prince M.R., Arnoldus C., and Frisoli J.K. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imag 6 (1996) 162-166
3. Reiter-Theil S. Ethical aspects of screening and preventive diagnosis with radiological imaging. In: Reiser M.F., van Kaick G., Fink C., et al. (Eds). Preventive diagnosis with radiological imaging (2008), Springer, Berlin Heidelberg 137-146
4. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. URL: http://www.nsc.nhs.uk/pdfs/criteria.pdf (as assessed on Dec 20th, 2008).
5. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Papers No. 34, WHO 1968. URL: http://whqlibdoc.who.int/php/WHO_PHP_34.pdf (as assessed on Dec 20th, 2008).
6. La Veccia C., Luccini F., Negri E., Boyle P., Maisonneuve P., and Levi F. Trends in cancer mortality in Europe, 1955-1989: III, breast and genital sites. Eur J Cancer 28 (1992) 927-998
7. Neuhaus H. Screening for colorectal cancer in Germany: guidelines and reality. Endoscopy 31 (1999) 468-470
8. Villavicencio R.T., and Rex D.X. Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin Gastrointest Dis 11 (2000) 185-193
9. Chambless L., Keil U., Dobson A., et al. Population versus clinical view of case fatality from acute coronary heart disease-results from the WHO Monica project 1985-1990. Circulation 96 (1997) 3849-3859
10. Fuster V., and Pearson T.A. 27th Bethesda conference. Matching the intensity of risk factor management with the hazard for coronary heart disease events. J Am Coll Cardiol 27 (1996) 957-1047
11. Ruehm S.G., Goyen M., Barkhausen J., et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357 (2001) 1086-1091
12. Fenchel M., Jost D., Kramer U., et al. Cardiovascular whole-body MR imaging in patients with symptomatic peripheral arterial occlusive disease. Rofo 178 5 (2006) 491-499
13. Ganguli S., Pedrosa I., Smith M.P., Niendorf E.R., Fredericks S., and Rofsky N.M. Low dose pedal magnetic resonance angiography at 3 tesla with time-resolved imaging of contrast kinetics: a feasibility study. Invest Radiol 43 9 (2008) 650-655
14. Van der Geest R.J., and Reiber J.H.C. Quantification in cardiac MRI. J Magn Reson Imag 10 (1999) 602-608
15. Barkhausen J., Ruehm S.G., Goyen M., Buck T., Laub G., and Debatin J.F. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 219 (2001) 264-269
16. Hunold P., Brandt-Mainz K., Freudenberg L., et al. Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging-comparison of the late enhancement technique with positronemission tomography. Rofo 174 (2002) 867-873
17. Klein C., Nekolla S.G., Bengel F.M., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 (2002) 162-167
18. Lundblad D., and Eliasson M. Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study. Cardiovasc Diabetol 2 (2003) 9
19. Hirai T., Korogi Y., Ono K., et al. Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol 23 (2002) 93-101
20. Kim D.E., Bae H.J., Lee S.H., Kim H., Yoon B.W., and Roh J.K. Gradient echo magnetic resonance imaging in the prediction of hemorrhagic vs ischemic stroke: a need for the consideration of the extent of leukoariosis. Arch Neurol 59 (2002) 425-429
21. Wong T.Y., Klein R., Sharrett A.R., et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288 (2002) 67-74
22. Vermeer S.E., Hollander M., van Dijk E.J., Hofman A., Koudstaal P.J., Breteler M.M., and Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34 5 (2003) 1126-1129
23. Starr J.M., Leaper S.A., Murray A.D., et al. Brain white matter lesions detected by magnetic resonancecorrection of resonance imaging are associated with balance and gait speed. Neurol Neurosurg Psychiatry 74 (2003) 94-98
24. Herskovits E.H., Itoh R., and Melhem E.R. Accuracy for detection of simulated lesions: comparison of fluidattenuated inversion-recovery, proton density-weighted, and T2-weighted synthetic brain MR imaging. AJR Am J Roentgenol 176 (2001) 1313-1318
25. Lauenstein T.C., Goehde S.C., Herborn C.U., et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 min: a feasibility study. AJR Am J Roentgenol 179 (2002) 445-449
26. Vogt F.M., Herborn C.U., Hunold P., et al. HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 183 1 (2004) 71-78
27. Bepler G., Goodridge C.D., Djulbegovic B., Clark R.A., and Tockman M. A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 10 4 (2003) 306-314
28. Ajaj W., Pelster G., Treichel U., et al. Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology. Gut 52 12 (2003) 1738-1743
29. Schaefer J.F., Fischmann A., Lichy M., et al. Onkologische Früherkennung mit der Ganzkörper-MRT: Möglichkeiten und Grenzen. Radiologe 44 (2004) 854-863
30. Gohde S.C., Goyen M., Forsting M., and Debatin J.F. Prevention without radiation-a strategy for comprehensive early detection using magnetic resonance tomography. Radiologe 42 (2002) 622-629
31. Fenchel M., Scheule A.M., Stauder N.I., et al. Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology-initial clinical results. Radiology 238 (2006) 280-291
32. Goehde S.C., Hunold P., Vogt F.M., et al. Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR Am J Roentgenol 184 (2005) 598-611
33. Weckbach S., Findeisen H., Schoenberg S.O., et al. Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with magnetic resonance imaging/magnetic resonance angiography. Invest Radiol. 44 4 (2009) 242-250
34. Kanjwal M.K., Cooper C., and Bashir R. Peripheral arterial disease-the silent killer. JK-Practitioner 11 (2004) 225-232
35. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119 (1993) 1187-1197
36. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
37. Assmann G., and Schulte H. The Prospective Cardiovascular Munster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am J Cardiol 59 (1987) 9G-17G
38. Schmermund A., Stang A., Mohlenkamp S., et al. Prognostic value of electron-beam computed tomography-derived coronary calcium scores compared with clinical parameters in patients evaluated for coronary artery disease. Prognostic value of EBCT in symptomatic patients. Z Kardiol 93 (2004) 696-705
39. Shaw L.J., Raggi P., Schisterman E., Berman D.S., and Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228 (2003) 826-833
40. Rockman C.B., Jacobowitz G.R., Gagne P.J., et al. Focused screening for occult carotid artery disease: patients with known heart disease are at high risk. J Vasc Surg 39 (2004) 44-51
41. Nikolsky E., Mehran R., Mintz G.S., et al. Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions. J Endovasc Ther 11 (2004) 60-70
42. Januzzi Jr. J.L., Buros J., and Cannon C.P. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial. Clin Cardiol 28 (2005) 238-242
43. Nicoloff A.D., Taylor Jr. L.M., Sexton G.J., et al. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease. J Vasc Surg 35 (2002) 38-46
44. Rigatelli G. Aortoiliac angiography during coronary artery angiography detects significant occult aortoiliac and renal artery atherosclerosis in patients with coronary atherosclerosis. Int J Cardiovasc Imag 20 (2004) 299-303
45. Naghavi M. Preventive cardiology: the SHAPE of the future. A Synopsis from the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Herz 32 (2007) 356-361
46. Meaney J.F., Ridgway J.P., Chakraverty S., et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211 (1999) 59-67
47. Zenge M.O., Vogt F.M., Brauck K., et al. High-resolution continuously acquired peripheral MR angiography featuring partial parallel imaging GRAPPA. Magn Reson Med 56 (2006) 859-865
48. Schoenberg S.O., Aumann S., Just A., et al. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis. Magn Reson Med 49 2 (2003) 288-298
49. Lauenstein T.C., Ajaj W., Narin B., et al. MR imaging of apparent small-bowel perfusion for diagnosing mesenteric ischemia: feasibility study. Radiology 234 2 (2005) 569-575
50. Waugh N., Black C., Walker S., McIntyre L., Cummins E., and Hillis G. The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review. Health Technol Assess 10 (2006) 39
51. Raggi P., Davidson M., Callister T.Q., et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112 (2005) 563-571
52. Arad Y., Spadaro L.A., Roth M., Newstein D., and Guerci A.D. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 46 (2005) 166-172
53. Baumgart D., and Egelhof T. Preventive whole-body screening encompassing modern imaging using magnetic resonance tomography. Herz 32 5 (2007) 387-394
54. Hansen T., Wikström J., Johansson L.O., Lind L., and Ahlström H. The prevalence and quantification of atherosclerosis in an elderly population assessed by whole-body magnetic resonance angiography. Arterioscler Thromb Vasc Biol 27 3 (2007) 649-654
55. Ladd SC, Wanke I, Gizewski ER, Forsting M. First results of a prospective whole-body MR screening study. Congress of Radiology, 2007, Vienna, Austria, Proceedings, p. 286.
56. Kramer H., Schoenberg S.O., Nikolaou K., et al. Cardiovascular screening with parallel imaging techniques and a whole-body MR imaging. Radiology 236 (2005) 300-310
57. Vernooij M.W., Ikram M.A., Tanghe H.L., et al. Incidental findings on brain MRI in the general population. N Engl J Med 357 18 (2007) 1821-1828
58. Corrado E., Rizzo M., Coppola G., Muratori I., Carella M., and Novo S. Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis 19 3 (2008) 139-144
59. Seeger A., Grimm F., Fenchel M., et al. Cardiac MRI in addition to MR angiography: a longitudinal study in vascular risk patients. Rofo 180 5 (2008) 423-429
60. Goyen M., Herborn C.U., Kröger K., Ruehm S.G., and Debatin J.F. Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol 16 3 (2006) 685-691
61. Ladd S.C., Debatin J.F., Stang A., et al. Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol 17 4 (2007) 1035-1045
62. Nassenstein K., Breuckmann F., Lehmann N., et al. Left ventricular volumes and mass in marathon runners and their association with cardiovascular risk factors. Int J Cardiovasc Imag 25 1 (2009) 71-79
63. Mark P.B., Doyle A., Blyth K.G., et al. Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. J Cardiovasc Magn Reson 18 10 (1) (2008) 39
64. Brauck K., Breuckmann F., Barkhausen J., and Ladd S.C. Concomitant atherosclerotic changes in whole-body MR-Angiography and coronary calcium deposit in patients with catheter-staged coronary artery disease. Proc. ISMRM abstract no 1965. Seattle, USA (2006) 388
65. Hansen T., Ahlstrom H., Wikstrom J., Lind L., and Johansson L. A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors. Eur Radiol 18 (2008) 1174-1180
66. Kinner S., Kuehle C.A., Langhorst J., et al. MR colonography vs. optical colonoscopy: comparison of patients' acceptance in a screening population. Eur Radiol 17 9 (2007) 2286-2293
67. Lo G.G., Ai V., Au-Yeung K.M., Chan J.K., Li K.W., and Chien D. Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors. Hong Kong Med J 14 2 (2008) 90-96
68. Filipas D., Spix C., Schulz-Lampel D., et al. Screening for renal cell carcinoma using ultrasonography: a feasibility study. BJU Int 91 7 (2003) 595-599
69. Perry K.A., Enestvedt C.K., Lorenzo C.S., et al. The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms. Gastrointest Surg 12 11 (2008) 1880-1887
70. Moore S.G., Shenoy P.J., Fanucchi L., Tumeh J.W., and Flowers C.R. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res 13 9 (1) (2009) 9
71. Pinsky P.F., Schoen R.E., Weissfeld J.L., et al. The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol 7 1 (2009) 86-92
72. Wyman R.A., Gimelli G., McBride P.E., Korcarz C.E., and Stein J.H. Does detection of carotid plaque affect physician behavior or motivate patients?. Am Heart J 154 6 (2007) 1072-1077
73. Takeuchi M., Matsuzaki K., Kubo H., and Nishitani H. Diffusion-weighted magnetic resonance imaging of urinary epithelial cancer with upper urinary tract obstruction: preliminary results. Acta Radiol 49 10 (2008) 1195-1199
74. Kruger D.G., Riederer S.J., Grimm R.C., and Rossman P.J. Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 47 2 (2002) 224-231
75. Sommer G., Fautz H.P., Ludwig U., and Hennig J. Multicontrast sequences with continuous table motion: a novel acquisition technique for extended field of view imaging. Magn Reson Med 55 4 (2006) 918-922